OABI

OmniAb, Inc. - Common Stock (OABI)

About OmniAb, Inc. - Common Stock (OABI)

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Details

Daily high

$2.21

Daily low

$2.03

Price at open

$2.19

52 Week High

$4.96

52 Week Low

$1.22

Market cap

266.2M

Dividend yield

0.00%

Volume

711,194

Avg. volume

697,619

P/E ratio

-3.72

OmniAb, Inc. - Common Stock News